We are excited to announce that Phenomix Sciences founder and CEO, Dr. Andres Acosta was featured in this month's issue of Scientific American! In the article Mind Over Meal, Dr. Acosta discusses the complex signaling involved in the gut-brain axis and how treatments must be selected based on each patient's unique abnormalities to guide effective weight loss outcomes.
The article also features a fresh perspective for how bariatric surgery is actually responsible for producing weight loss. (Hint: it involves the same complex signaling pathways that we are analyzing with the Phenomix test!)
Congratulations Dr. Acosta for the in depth feature in Scientific American!
Wefunder supports three different federal laws that allow startups to raise money legally. To comply with the law, Wefunder Advisors LLC and Wefunder Portal LLC (both owned by Wefunder Inc) also list startups depending on the regulation used.
Legal May 16th 2016
Wefunder Portal LLC
for 250 startups
Wefunder Advisors LLC
for 98 startups
for 2 startups
Curious how well the companies have done? Or how many raised follow-on financing?
Some fine print: 1) These numbers include startups currently live on Wefunder if they pass their minimum target. 2) Some startups use two different laws at the same time (i.e., Regulation D and Regulation Crowdfunding).
Join 467,850 investors who funded 336 startups with over $119 million1
wefunder.com/updates/99237-dr-acosta-featured-in-scientific-american is managed by
Wefunder Portal LLC.
Wefunder Inc. runs wefunder.com and is the parent company of Wefunder Advisors LLC and Wefunder Portal LLC. Wefunder Advisors is an exempt reporting adviser that advises SPVs used in Reg D offerings. Wefunder Portal is a funding portal (CRD #283503) that operates sections of wefunder.com where some Regulation Crowdfunding offerings are made.
Wefunder, Inc. operates sections of wefunder.com where some Regulation D and A offerings are made. Wefunder, Inc. is not regulated as either a broker-dealer or funding portal and is not a member of FINRA.
You may also view our Privacy Notice.